Clinical trial
Phase III Study of Preoperative vs Postoperative Intensity Modulated Radiation Therapy For Truncal/Extremity Soft Tissue Sarcoma
NCT02565498 is registered in ClinicalTrials.gov with Mount Sinai Hospital, Canada as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase III Study of Preoperative vs Postoperative Intensity Modulated Radiation Therapy For Truncal/Extremity Soft Tissue Sarcoma
- Lead sponsor
- Mount Sinai Hospital, Canada
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- June 30, 2016
- Completion date
- May 31, 2029
- Enrollment
- 210 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
adult soft tissue sarcoma